Sample pages - Gale
Sample pages - Gale
Sample pages - Gale
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
04139 INTERVET COLOMBIA LTDA COLOMBIA<br />
Financial Information:<br />
31.12.09 31.12.10<br />
COP’000 COP’000<br />
Sales turnover 283,304,936 332,030,284<br />
Profit before tax 19,895,040 39,974,950<br />
Profit after tax 11,551,519 27,291,319<br />
Share capital 38,409,684 38,409,684<br />
Shareholders’ equity 160,815,558 175,383,976<br />
04139<br />
INTERVET COLOMBIA LTDA<br />
Address: Avenida Carrera 68 N0 17-64, Costado Occidental,<br />
Bogotá DC<br />
International tel: +57 (1) 417 5466<br />
International fax: +57 (1) 676 1080<br />
Website: www.intervet.com.co<br />
Company Registration Number: 830015923<br />
Management: Angelo Bolis Delair (Representante Legal),<br />
Steven Koehler (Gerente), Ricardo Rodriguez Chala (Contador),<br />
Michiel Stijn (Gerente)<br />
PRINCIPAL ACTIVITIES: Wholesale trade in animal healthcare<br />
products<br />
Parent Company: Merck & Co Inc., USA<br />
Status: Limited Liability Company<br />
Principal Shareholders: Merck & Co Inc., USA<br />
Financial Information:<br />
31.12.09 31.12.10<br />
COP’000 COP’000<br />
Sales turnover 26,164,750 41,509,987<br />
Profit before tax 1,626,129 5,345,163<br />
Profit after tax 943,607 3,505,693<br />
Share capital 777,550 777,550<br />
Shareholders’ equity 3,740,314 7,064,340<br />
04140<br />
JOHNSON & JOHNSON DE COLOMBIA S.A.<br />
J&J DE COLOMBIA SA<br />
Address: Apartado Postal 6530, Calle 15 No.31-146,<br />
Yumbo, Valle del Cauca<br />
International tel: +57 (2) 651 3333<br />
International fax: +57 (2) 651 3462<br />
Website: www.jnjcolombia.com.co<br />
Company Registration Number: 890101815<br />
Board of Directors: Martha Lucia Echeverry Piñeres (Director),<br />
Walter Grundy (Director), Adolfo Ignacio Ibarra Garcia<br />
(Director), Rosana Padilla Guevara (Representante Legal),<br />
Álvaro Palacio Restrepo (Gerente)<br />
Management: Luis Casallas Jimenez (Contador)<br />
PRINCIPAL ACTIVITIES: Manufacture of toiletries and pharmaceuticals<br />
Parent Company: Johnson & Johnson, USA<br />
Status: Non Quoted Public Company<br />
Principal Shareholders: Johnson & Johnson, USA<br />
Date of Establishment: 5 December 1962<br />
Financial Information:<br />
31.12.09 31.12.10<br />
COP’000 COP’000<br />
Sales turnover 618,617,523 661,504,288<br />
Profit before tax 67,776,661 68,557,686<br />
Profit after tax 42,723,961 46,464,929<br />
Share capital 1,852,846 1,852,846<br />
Shareholders’ equity 287,559,498 282,683,276<br />
04141<br />
LABORATORIOS BAXTER S.A.<br />
Address: Apartado Postal 2446, Calle 36 No.2C-22, Cali<br />
International tel: +57 (2) 444 7275; +57 (2) 444 7000<br />
International fax: +57 (2) 444 7412<br />
Website: www.latinoamerica.baxter.com/colombia<br />
Company Registration Number: 890300292<br />
Management: Mario Ciardelli Medina (Representante Legal),<br />
César Augusto González Ospina (Gerente), Carlos Alberto<br />
Roldan Aragon (Gerente), Hector Fauro Vargas Gutierrez<br />
(Contador)<br />
PRINCIPAL ACTIVITIES: Manufacture of pharmaceuticals<br />
Parent Company: Baxter International Inc, USA<br />
Status: Non Quoted Public Company<br />
Principal Shareholders: Baxter International Inc, USA<br />
536<br />
Financial Information:<br />
31.12.09 31.12.10<br />
COP’000 COP’000<br />
Sales turnover 525,103,917 547,374,636<br />
Profit before tax 122,665,101 159,258,131<br />
Profit after tax 83,187,057 107,577,164<br />
Share capital 1,000,926 1,000,926<br />
Shareholders’ equity 465,921,888 493,688,083<br />
04142<br />
MERCK S.A.<br />
Address: Calle 10 No. 65 28, Bogotá DC<br />
International tel: +57 (1) 425 4770<br />
International fax: +57 (1) 420 7819<br />
Company email: mcsa@merck.com.co<br />
Website: www.merck.com.co<br />
Company Registration Number: 860000580<br />
Board of Directors: Hernán Alfonso Briceño Rodríguez (Representante<br />
Legal), Carlos Arturo García Montoya (Director),<br />
Esteban Serrano Luciano (Director)<br />
Management: Luz Mery López Lagos (Gerente), Gladys Stella<br />
Lorenzana Huertas (Contador)<br />
PRINCIPAL ACTIVITIES: Manufacture of chemicals for use in<br />
the pharmaceutical and of pharmaceutical preparations<br />
Parent Company: Merck KGaA (02705)<br />
Status: Non Quoted Public Company<br />
Principal Shareholders: Merck KGaA, Germany<br />
Date of Establishment: 1957<br />
No of Employees: 523<br />
Financial Information:<br />
31.12.09 31.12.10<br />
COP’000 COP’000<br />
Sales turnover 320,061,690 278,006,162<br />
Profit before tax 73,916,856 37,215,672<br />
Profit after tax 50,079,535 24,879,572<br />
Share capital 14,356,030 14,356,030<br />
Shareholders’ equity 124,538,491 105,894,170<br />
04143<br />
NOVARTIS DE COLOMBIA S.A.<br />
NOVARTIS<br />
Address: Apartado Postal 123234, Calle 11 No.65-51,<br />
Bogotá DC<br />
International tel: +57 (1) 654 4444<br />
International fax: +57 (1) 446 4815<br />
Website: www.novartis.com<br />
Company Registration Number: 860002538<br />
Board of Directors: Maria Cristina Alvarez Rodriguez (Representante<br />
Legal), Jean Claude Dubos (Director), Carlos<br />
Dicken Garcia Iragorri (Director)<br />
Management: Carlos Leonardo Garcia Hewitt (Gerente),<br />
Evelyn Peña (Contador), Guillermo José Quintero Perdomo<br />
(Gerente)<br />
PRINCIPAL ACTIVITIES: Wholesale trade in pharmaceuticals<br />
aiming to prevent and cure diseases, to ease suffering and<br />
to enhance the quality of life<br />
Parent Company: Novartis AG (03653)<br />
Status: Non Quoted Public Company<br />
Principal Shareholders: Novartis AG, Switzerland (100%)<br />
Financial Information:<br />
31.12.09 31.12.10<br />
COP’000 COP’000<br />
Sales turnover 321,017,516 361,448,213<br />
Profit before tax 19,983,915 38,131,536<br />
Profit after tax 13,739,070 23,252,553<br />
Share capital 7,934,807 7,934,807<br />
Shareholders’ equity 113,709,095 100,584,514<br />
04144<br />
PFIZER S.A.<br />
PFIZER<br />
Address: Avenida El Dorado No.68B-85, Bogotá DC<br />
International tel: +57 (1) 417 8507<br />
International fax: +57 (1) 427 0070<br />
Website: www.pfizer.com.co<br />
Company Registration Number: 860039561<br />
Board of Directors: Luis Alberto Acuña González (Director),<br />
Luis Fernando Molano (Director), Francisco A Rodríguez<br />
Rodríguez (Director)<br />
Management: Juan Carlos Avila Bustos (Contador), Claudia<br />
Johanna Bohorquez Leon (Gerente), Andres Jordan Herrera<br />
(Representante Legal)<br />
PRINCIPAL ACTIVITIES: Wholesale trade in pharmaceuticals<br />
for human and veterinary use<br />
Parent Company: Pfizer Inc, USA<br />
Status: Non Quoted Public Company<br />
Principal Shareholders: Pfizer Inc, USA<br />
Financial Information:<br />
31.12.09 31.12.10<br />
COP’000 COP’000<br />
Sales turnover 280,354,399 472,014,510<br />
Profit before tax 32,416,267 21,092,880<br />
Profit after tax 18,947,634 13,203,872<br />
Share capital 30,332,357 30,332,357<br />
Shareholders’ equity 91,080,461 81,304,138<br />
04145<br />
PROCTER & GAMBLE COLOMBIA LTDA<br />
P & G Colombia Ltda<br />
Address: Apartado Postal 94611, Carrera 7 No.114-33, Piso<br />
12, Bogotá DC<br />
International tel: +57 (1) 520 8000<br />
International fax: +57 (1) 640 0013<br />
Website: www.pg.com<br />
Company Registration Number: 800000946<br />
Management: Carlos Alfredo Giraldo Aly (Representante Legal),<br />
Rafael Molina (Contador), Juan David Valencia Ocampo<br />
(Gerente), Víctor Karlo Velazquez Patron (Gerente)<br />
PRINCIPAL ACTIVITIES: Wholesale trade in personal care<br />
products, household cleaning items, laundry detergents,<br />
prescription drugs and disposable nappies<br />
Trade Names: Ariel, Pantele, Pert Plus, Camay, Crest<br />
Parent Company: Procter & Gamble Company, USA<br />
Status: Limited Liability Company<br />
Principal Shareholders: Procter & Gamble Company, USA<br />
Financial Information:<br />
31.12.09 31.12.10<br />
COP’000 COP’000<br />
Sales turnover 691,831,680 753,006,926<br />
Profit before tax 20,194,656 65,237,458<br />
Profit after tax 8,916,973 42,511,884<br />
Share capital 32,212,968 32,212,968<br />
Shareholders’ equity 194,600,815 200,152,052<br />
04146<br />
PRODUCTOS ROCHE S.A.<br />
Address: Carrera 44 No.17-21, Bogotá DC<br />
International tel: +57 (1) 417 8860<br />
International fax: +57 (1) 337 9270<br />
Website: www.roche.com.co<br />
Company Registration Number: 860003216<br />
Board of Directors: Hector Feliu (Director), Rolf Erik Honger<br />
(Representante Legal), Jorg Michael Rupp (Director)<br />
Management: Rodrigo Alonso Gómez Burbano (Gerente),<br />
Edith Marisol López Borbón (Contador)<br />
PRINCIPAL ACTIVITIES: Wholesale trade in pharmaceuticals<br />
Parent Company: Roche Holding AG (03668)<br />
Status: Non Quoted Public Company<br />
Principal Shareholders: Roche Holding AG, Switzerland<br />
(100%)<br />
Financial Information:<br />
31.12.09 31.12.10<br />
COP’000 COP’000<br />
Sales turnover 553,829,987 556,832,268<br />
Profit before tax 26,838,624 11,262,446<br />
Profit after tax 18,173,009 9,224,135<br />
Share capital 26,923,689 26,923,689<br />
Shareholders’ equity 202,200,282 218,813,820<br />
04147<br />
SANOFI-AVENTIS PHARMA S.A.<br />
SANOFI<br />
Address: Apartado Postal 6161, Transversal 23 N. 97-73,<br />
Piso 9, Bogotá DC<br />
International tel: +57 (1) 621 8400<br />
International fax: +57 (1) 621 4400<br />
Website: www.sanofi-aventis.com<br />
Company Registration Number: 830010337<br />
Board of Directors: Mauricio Botero Caicedo (Representante<br />
Legal), Stephen Edward Cobhan Scott (Director), Jesus<br />
Hernando Cubides Ballesteros (Director)<br />
Management: Giovanni Castillo Moreno (Contador), Hernando<br />
Suárez Ramírez (Gerente)